BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹5.09 Cr | ₹5.07 Cr | ₹4.69 Cr | ₹4.07 Cr | ₹3.62 Cr |
What is the latest Long Term Provisions ratio of BAL PHARMA ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹5.09 Cr |
Mar2023 | ₹5.07 Cr |
Mar2022 | ₹4.69 Cr |
Mar2021 | ₹4.07 Cr |
Mar2020 | ₹3.62 Cr |
How is Long Term Provisions of BAL PHARMA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹5.09 Cr | 0.36 | |
Mar2023 | ₹5.07 Cr | 7.97 | |
Mar2022 | ₹4.69 Cr | 15.47 | |
Mar2021 | ₹4.07 Cr | 12.29 | |
Mar2020 | ₹3.62 Cr | - |
Compare Long Term Provisions of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹153.0 Cr | -3.2% | -11.8% | -6.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹423,771.0 Cr | -3.4% | -0.2% | 18.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,175.0 Cr | -2.3% | 3.4% | 55.5% | Stock Analytics | |
CIPLA | ₹120,076.0 Cr | -2.6% | -0.6% | 5.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,727.0 Cr | -2.3% | -2.1% | 20.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,853.9 Cr | -2.9% | -0.2% | -8.7% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | -3.2% |
-11.8% |
-6.9% |
SENSEX | 0.1% |
4.9% |
7.7% |
You may also like the below Video Courses